WEALTH & OTHER VICES #9. OUTSMARTING CHAOS, PRESERVING CAPITAL

This issue explores what it really takes to preserve wealth, stay ahead of technological change and remain in control of your life. We begin with the psychology of financial resilience: why managing debt, resisting the pressure to keep up with others, maintaining liquidity and preparing for the unexpected may matter more than chasing the highest returns. We then examine the gap between the promise of artificial intelligence and its impact on business performance, where the biggest gains depend less on buying new technology than on redesigning organisations around it. Turning to longevity, we challenge fashionable anti-ageing shortcuts and look at the foundations of lasting physical independence: muscle power, strong bones, movement and a mindset that keeps us engaged with life. Finally, we travel to Australia's tropical islands, where major investments are bringing forgotten pieces of paradise back to life, and consider the growing appeal of a luxury measured not in possessions but in privacy, nature and time. Along the way, we bring you conversations about capital, technology, luxury living and the business behind the world's hotel brands.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

WEALTH & OTHER VICES #8. AI’S GAS-TURBINE GRAVEYARD

This issue of WEALTH & OTHER VICES examines the fault lines emerging beneath the biggest investment and lifestyle trends of our time. We look at the extraordinary spending behind the AI boom, asking whether data centres, specialised chips and private power plants are becoming the next generation of stranded assets, and what happens when technological ambition collides with debt, falling prices and the limits of electricity supply. We then turn to China, where a rapidly advancing biotechnology industry is creating opportunities for global pharmaceutical investors, while the next generation of weight-loss drugs raises a different question: how do you lose weight without losing strength? Beyond the markets, we explore an unusual new luxury: paying someone simply to be there, with no advice, expectations or demands. And we finish with a look at how a Chinese tea brand is building its business by borrowing lessons from the world of global fast food.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

WEALTH & OTHER VICES #4. A CENTURY OF RETURNS. A LIFETIME OF LESSONS.

This issue explores how wealth is built, managed and redefined in a world where the rules of money, success and longevity are becoming increasingly complex. We look at what a century of market history can teach us about compounding, risk and the limits of forecasting; why even exceptional investors are struggling to build independent businesses in an industry dominated by giants; and how the pursuit of a longer life is turning ageing into a measurable, competitive pursuit. We also examine a different kind of value creation, as a company draws on its industrial expertise to help artists transform precious metals into works of cultural significance. From the long game of capital to the personal ambition to outlast time, this issue asks what wealth really means — and what remains valuable beyond the numbers.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Bryan Johnson: “People Really Want Me to Die”

Modern civilization has spent thousands of years encouraging people to trade their physical health for social status, wealth, and power. For centuries, individuals have been expected to sacrifice sleep, proper nutrition, and peace of mind in pursuit of career achievements or political influence. However, society is currently undergoing a fundamental cultural shift away from accepting death as an inevitable fate toward embracing a philosophy centered on preserving human life. The primary measure of success is shifting away from monetary wealth or expensive material possessions and moving toward measurable biological vitality. True achievement in this new paradigm looks like optimal sleep quality, strong fertility, and maintaining athletic physical performance well into middle age. Extending human lifespan to several centuries represents one of the most worthwhile investments humanity can make, as the living generation stands on the threshold of halting biological aging entirely.

Read More

Innovation and modern science are transforming women’s wellness

While women naturally outlive men globally, they spend 25% more of their total lives in poor health, enduring over a decade of preventable physical discomfort. For generations, medical research and clinical training overlooked female biology, leaving half the population with trial-and-error health solutions. Today, a major paradigm shift is underway. Groundbreaking advancements in longevity science, targeted clinical research, and specialized care are replacing outdated, one-size-fits-all models. By addressing key biological transitions—from early reproductive shifts to midlife hormonal resets—modern medicine is unlocking lifelong vitality. Driven by a $350 billion market demand, rising institutional support, and diverse healthcare leadership, this transformation ensures that living longer finally means living in full, vibrant health.

Read More

The Longevity Dividend

For affluent wealth owners, acting on the $9 trillion longevity megatrend requires a three-part playbook: systematically rebalance portfolios and wealth structures for extended lifespans; deploy capital into high-growth sectors like wellness real estate ($464bn), wellness tourism (+30% growth by 2028), and biotech; and optimize personal health span using advanced diagnostics—DNA sequencing, epigenetics, and metabolomics—combined with cellular therapies and daily lifestyle discipline. This pivots capital from material accumulation toward extended vitality, family well-being, and high-quality life experiences.

Read More

The GLP-1 effect: what happens after you stop being hungry?

The global expansion of GLP-1 therapies — such as Ozempic, Wegovy, and Mounjaro — is vastly misunderstood. This is not a pharmaceutical headline about weight loss or a clinical story — it is a $200 billion structural reallocation of global consumer capital. As biological hunger is systematically moderated across affluent markets, household expenditure is undergoing a permanent portfolio reset. Capital is fleeing volume-driven indulgence — processed foods, mass dining, and bulk alcohol — and compounding into a high-margin “longevity stack” centered on muscle preservation, real-time health intelligence, regenerative aesthetics, and vitality-focused luxury travel.

Read More